CHRISTOPHER M STARR
CIK 1235470 · Chief Executive Officer · last filed 2025-12-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.62M
Companies
3
Total Filings
63
Lifetime Open-Market Net
-$7.39M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MNPR | Director | 15,053 | $107.42 | $1.62M | -$672.0K | 22 | 2025-12-08 |
| Raptor Pharmaceutical Corp (RPTP) Delisted | Director | 0 | — | — | -$6.72M | 38 | 2016-10-26 |
| Raptor Pharmaceutical Corp (RPTPD) Delisted | Chief Executive Officer | 699,370 | — | — | $0 | 1 | 2009-10-01 |
Recent Filings · Page 4 of 7
63 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-02-19 | Raptor Pharmaceutical Corp (RPTP) Delisted | Mixed | — | -$174.9K | EDGAR |
| 2015-02-11 | Raptor Pharmaceutical Corp (RPTP) Delisted | Grant (A) | +1,674 | $0 | EDGAR |
| 2015-01-26 | Raptor Pharmaceutical Corp (RPTP) Delisted | Mixed | — | -$177.4K | EDGAR |
| 2015-01-20 | Raptor Pharmaceutical Corp (RPTP) Delisted | Mixed | — | -$185.8K | EDGAR |
| 2014-12-23 | Raptor Pharmaceutical Corp (RPTP) Delisted | Mixed | — | -$163.8K | EDGAR |
| 2014-12-17 | Raptor Pharmaceutical Corp (RPTP) Delisted | Mixed | — | -$138.4K | EDGAR |
| 2014-11-25 | Raptor Pharmaceutical Corp (RPTP) Delisted | Mixed | — | -$192.8K | EDGAR |
| 2014-11-19 | Raptor Pharmaceutical Corp (RPTP) Delisted | Mixed | — | -$191.0K | EDGAR |
| 2014-10-24 | Raptor Pharmaceutical Corp (RPTP) Delisted | Mixed | — | -$218.3K | EDGAR |
| 2014-10-17 | Raptor Pharmaceutical Corp (RPTP) Delisted | Mixed | — | -$212.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.